Forward together with innovation:The importance of policy making in the era of personalised medicine – 3-4 December 2019, Brussels, Belgium
The Belgian capital has been chosen to host the event as the new Parliament will be in place after the summer elections, while a new European Commission will be in the process of being formed, ready to formally move into the Berlaymont not long afterwards.
The event will be held under the auspices of the Finnish Presidency of the EU, which will run from July to December. The Congress is in a focused format to allow concrete issues to be tackled and to have a dialogue with our policy makers. Essentially, this 3rd annual Congress will provide the ideal space to allow for a meeting of minds and expertise and represent a vital opportunity for top-level discussion and the formulation of real action plans, for example in the area of translational research.
Congress will showcase different objectives which both the public and private sector can support, with a view to allowing the EU to present a common objective. Innovation and the incentives for it are key to health and wealth in the current EU-28 (and will be even more important after the UK leaves). It also encourages investment from outside of the EU, which is good for business and jobs. It is clear that innovation needs to soar to new heights, and be implemented and integrated, for the bene t of EU citizens.